Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Profound Medical Corp.

< Previous 1 2 Next >
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces First Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical AUA 2025 Investor Event Agenda
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Save the Date: Profound Medical to Host Investor Event at AUA 2025
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Proposed Public Offering of Common Shares
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Participate in the Stifel 2024 Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Third Quarter 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Second Quarter 2024 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
From Profound Medical Corp.
Via GlobeNewswire
Tickers PROF TSX:PRN
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.